Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

US Patent 12065499 · Granted Aug 20, 2024

Estimated economic value: $50,631,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa2025
Anti-CD40 antibodies for use in treatment of hidradenitis suppurativa2025
Anti-CD40 antibodies for use in prevention of graft rejection2023
Anti-CD40 antibodies for use in prevention of graft rejection2023
Treatment of graft versus host disease in transplant patients2022
Method of treating transplant rejection with silent Fc variants of anti-CD40 ant2021
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2019
Nucleic acids encoding silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2017
Silent Fc variants of anti-CD40 antibodies2015
Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflam2015
Silent Fc variants of anti-CD40 antibodies2014